Back to Search
Start Over
Supplementary Figure 1 from Retargeted Oncolytic Measles Strains Entering via the EGFRvIII Receptor Maintain Significant Antitumor Activity against Gliomas with Increased Tumor Specificity
- Publication Year :
- 2023
- Publisher :
- American Association for Cancer Research (AACR), 2023.
-
Abstract
- Supplementary Figure 1 from Retargeted Oncolytic Measles Strains Entering via the EGFRvIII Receptor Maintain Significant Antitumor Activity against Gliomas with Increased Tumor Specificity
Details
- Database :
- OpenAIRE
- Accession number :
- edsair.doi.dedup.....47efa4812020ba7737e1d5cc51877814
- Full Text :
- https://doi.org/10.1158/0008-5472.22366586